|
Real-time
OTC Markets
16:30:13 28/01/2026 GMT
|
5-day change | 1st Jan Change | ||
| 178.29 USD | -8.57% |
|
-.--% | +1.59% |
| 01:02pm | Owkin signs AI drug discovery deal with Boehringer for cancer, immunology | RE |
| 11:49am | AstraZeneca PLC : Deutsche Bank reiterates its Sell rating | ZD |
| Market Cap | 251B 217B 204B 186B 349B 23,820B 351B 2,408B 937B 12,117B 942B 922B 40,178B | P/E 2026 * |
20.8x | P/E 2027 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 270B 233B 219B 200B 376B 25,655B 378B 2,593B 1,009B 13,050B 1,015B 993B 43,271B | EV / Sales 2026 * |
4.27x | EV / Sales 2027 * | 3.93x |
| Free-Float |
96.63% | Yield 2026 * |
2.06% | Yield 2027 * | 2.2% |
Last Transcript : AstraZeneca PLC
| 1 day | -8.57% |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 30/09/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 31/07/2021 |
Jeffrey Pott
CMP | Compliance Officer | - | 31/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 05/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 30/09/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 26/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.57% | -.--% | - | - | 251B | |
| +1.04% | -1.14% | +59.94% | +110.65% | 1,034B | |
| +1.15% | +1.93% | +54.55% | +71.27% | 654B | |
| -0.46% | -1.26% | +22.49% | +77.68% | 459B | |
| +0.65% | -4.83% | +33.78% | +36.04% | 343B | |
| -0.05% | +2.83% | +29.23% | +46.89% | 307B | |
| +0.26% | -1.60% | +1.13% | +12.61% | 251B | |
| -0.19% | -0.51% | +52.69% | +72.48% | 237B | |
| +2.67% | -1.02% | -15.79% | -53.94% | 202B | |
| -0.19% | +1.26% | +33.05% | +99.52% | 186B | |
| Average | -0.34% | -2.88% | +30.12% | +52.58% | 407.95B | |
| Weighted average by Cap. | +0.07% | -3.31% | +39.28% | +68.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.24B 54.55B 51.31B 46.75B 87.9B 6,002B 88.38B 607B 236B 3,053B 237B 232B 10,123B | 66.82B 57.64B 54.22B 49.39B 92.88B 6,342B 93.39B 641B 249B 3,226B 251B 245B 10,696B |
| Net income | 12.02B 10.37B 9.75B 8.89B 16.71B 1,141B 16.8B 115B 44.89B 580B 45.14B 44.16B 1,924B | 13.61B 11.74B 11.04B 10.06B 18.92B 1,292B 19.02B 131B 50.82B 657B 51.1B 49.99B 2,179B |
| Net Debt | 19.33B 16.67B 15.68B 14.29B 26.86B 1,834B 27.01B 185B 72.16B 933B 72.56B 70.99B 3,094B | 11.65B 10.05B 9.45B 8.61B 16.2B 1,106B 16.28B 112B 43.5B 563B 43.75B 42.8B 1,865B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
